Interestingly, our research also suggests cholesterol can affect glucose metabolism and potentially improve glucose metabolism in mice with NAFLD, possibly through mediated upregulation of HIF1A. This evidence concerns the gene HIF1A and metabolic dysfunction-associated steatotic liver disease.